
“Breaking News: LIXTE Biotechnology Announces $1.05M Registered Direct Offering Under Nasdaq Rules!”
Exciting News from LIXTE Biotechnology! A New Chapter for LIXTE It’s always thrilling to hear about new developments in the pharmaceutical industry, and today is no exception. LIXTE Biotechnology Holdings, Inc. has just announced that it will be entering into definitive agreements for the purchase and sale of shares of its common stock in a…